Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1997 Jan 15;99(2):200–208. doi: 10.1172/JCI119148

Impaired arterial neointima formation in mice with disruption of the plasminogen gene.

P Carmeliet 1, L Moons 1, V Ploplis 1, E Plow 1, D Collen 1
PMCID: PMC507787  PMID: 9005988

Abstract

To define the role of plasminogen (Plg) in the smooth muscle cell response after arterial wall injury, neointima formation was evaluated after electric injury of the femoral artery in plasminogen-deficient (Plg-/-) mice. The injury destroyed all medial smooth muscle cells, denuded the injured segment of intact endothelium, and induced transient platelet-rich mural thrombosis. In wild-type (Plg+/+) mice, vascular wound healing was characterized by lysis of the thrombus, transient infiltration of inflammatory cells, and progressive removal of necrotic debris and thrombosis. Topographic analysis revealed repopulation of the media and accumulation in the neointima of smooth muscle cells originating from the noninjured borders, which progressed into the necrotic center. In Plg-/- mice, wound healing was significantly impaired with delayed removal of necrotic debris, reduced leucocyte infiltration and smooth muscle cell accumulation, and decreased neointima formation. Smooth muscle cells accumulated at the uninjured borders, but failed to migrate into the necrotic center. Proliferation of smooth muscle cells was not affected by Plg deficiency. Evans blue staining revealed no genotypic differences in reendothelialization. Thus, Plg plays a significant role in vascular wound healing and arterial neointima formation after injury, most likely by affecting cellular migration.

Full Text

The Full Text of this article is available as a PDF (388.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ASTRUP T., MULLERTZ S. The fibrin plate method for estimating fibrinolytic activity. Arch Biochem Biophys. 1952 Oct;40(2):346–351. doi: 10.1016/0003-9861(52)90121-5. [DOI] [PubMed] [Google Scholar]
  2. Bendeck M. P., Zempo N., Clowes A. W., Galardy R. E., Reidy M. A. Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat. Circ Res. 1994 Sep;75(3):539–545. doi: 10.1161/01.res.75.3.539. [DOI] [PubMed] [Google Scholar]
  3. Bertozzi P., Astedt B., Zenzius L., Lynch K., LeMaire F., Zapol W., Chapman H. A., Jr Depressed bronchoalveolar urokinase activity in patients with adult respiratory distress syndrome. N Engl J Med. 1990 Mar 29;322(13):890–897. doi: 10.1056/NEJM199003293221304. [DOI] [PubMed] [Google Scholar]
  4. Betz E., Schlote W. Responses of vessel walls to chronically applied electrical stimuli. Basic Res Cardiol. 1979 Jan-Feb;74(1):10–20. doi: 10.1007/BF01907681. [DOI] [PubMed] [Google Scholar]
  5. Carmeliet P., Schoonjans L., Kieckens L., Ream B., Degen J., Bronson R., De Vos R., van den Oord J. J., Collen D., Mulligan R. C. Physiological consequences of loss of plasminogen activator gene function in mice. Nature. 1994 Mar 31;368(6470):419–424. doi: 10.1038/368419a0. [DOI] [PubMed] [Google Scholar]
  6. Clowes A. W., Clowes M. M., Au Y. P., Reidy M. A., Belin D. Smooth muscle cells express urokinase during mitogenesis and tissue-type plasminogen activator during migration in injured rat carotid artery. Circ Res. 1990 Jul;67(1):61–67. doi: 10.1161/01.res.67.1.61. [DOI] [PubMed] [Google Scholar]
  7. Clowes A. W., Clowes M. M., Kirkman T. R., Jackson C. L., Au Y. P., Kenagy R. Heparin inhibits the expression of tissue-type plasminogen activator by smooth muscle cells in injured rat carotid artery. Circ Res. 1992 Jun;70(6):1128–1136. doi: 10.1161/01.res.70.6.1128. [DOI] [PubMed] [Google Scholar]
  8. Clowes A. W., Reidy M. A., Clowes M. M. Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium. Lab Invest. 1983 Sep;49(3):327–333. [PubMed] [Google Scholar]
  9. Clowes A. W., Reidy M. A., Clowes M. M. Mechanisms of stenosis after arterial injury. Lab Invest. 1983 Aug;49(2):208–215. [PubMed] [Google Scholar]
  10. Clowes A. W., Reidy M. A. Prevention of stenosis after vascular reconstruction: pharmacologic control of intimal hyperplasia--a review. J Vasc Surg. 1991 Jun;13(6):885–891. doi: 10.1067/mva.1991.27929. [DOI] [PubMed] [Google Scholar]
  11. Collen D., Lijnen H. R. Basic and clinical aspects of fibrinolysis and thrombolysis. Blood. 1991 Dec 15;78(12):3114–3124. [PubMed] [Google Scholar]
  12. Dilley R. J., McGeachie J. K., Tennant M. The role of cell proliferation and migration in the development of a neo-intimal layer in veins grafted into arteries, in rats. Cell Tissue Res. 1992 Aug;269(2):281–287. doi: 10.1007/BF00319619. [DOI] [PubMed] [Google Scholar]
  13. Dollery C. M., McEwan J. R., Henney A. M. Matrix metalloproteinases and cardiovascular disease. Circ Res. 1995 Nov;77(5):863–868. doi: 10.1161/01.res.77.5.863. [DOI] [PubMed] [Google Scholar]
  14. Douek P. C., Correa R., Neville R., Unger E. F., Shou M., Banai S., Ferrans V. J., Epstein S. E., Leon M. B., Bonner R. F. Dose-dependent smooth muscle cell proliferation induced by thermal injury with pulsed infrared lasers. Circulation. 1992 Oct;86(4):1249–1256. doi: 10.1161/01.cir.86.4.1249. [DOI] [PubMed] [Google Scholar]
  15. Eitzman D. T., McCoy R. D., Zheng X., Fay W. P., Shen T., Ginsburg D., Simon R. H. Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene. J Clin Invest. 1996 Jan 1;97(1):232–237. doi: 10.1172/JCI118396. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Estreicher A., Mühlhauser J., Carpentier J. L., Orci L., Vassalli J. D. The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes. J Cell Biol. 1990 Aug;111(2):783–792. doi: 10.1083/jcb.111.2.783. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Glagov S., Ts'ao C. H. Restitution of aortic wall after sustained necrotizing transmural ligation injury. Role of blood cells and artery cells. Am J Pathol. 1975 Apr;79(1):7–30. [PMC free article] [PubMed] [Google Scholar]
  18. Idell S., James K. K., Levin E. G., Schwartz B. S., Manchanda N., Maunder R. J., Martin T. R., McLarty J., Fair D. S. Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome. J Clin Invest. 1989 Aug;84(2):695–705. doi: 10.1172/JCI114217. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Jackson C. L., Raines E. W., Ross R., Reidy M. A. Role of endogenous platelet-derived growth factor in arterial smooth muscle cell migration after balloon catheter injury. Arterioscler Thromb. 1993 Aug;13(8):1218–1226. doi: 10.1161/01.atv.13.8.1218. [DOI] [PubMed] [Google Scholar]
  20. Jackson C. L., Reidy M. A. The role of plasminogen activation in smooth muscle cell migration after arterial injury. Ann N Y Acad Sci. 1992 Dec 4;667:141–150. doi: 10.1111/j.1749-6632.1992.tb51606.x. [DOI] [PubMed] [Google Scholar]
  21. Lindner V., Fingerle J., Reidy M. A. Mouse model of arterial injury. Circ Res. 1993 Nov;73(5):792–796. doi: 10.1161/01.res.73.5.792. [DOI] [PubMed] [Google Scholar]
  22. Lupu F., Heim D. A., Bachmann F., Hurni M., Kakkar V. V., Kruithof E. K. Plasminogen activator expression in human atherosclerotic lesions. Arterioscler Thromb Vasc Biol. 1995 Sep;15(9):1444–1455. doi: 10.1161/01.atv.15.9.1444. [DOI] [PubMed] [Google Scholar]
  23. Matsushima K., Taguchi M., Kovacs E. J., Young H. A., Oppenheim J. J. Intracellular localization of human monocyte associated interleukin 1 (IL 1) activity and release of biologically active IL 1 from monocytes by trypsin and plasmin. J Immunol. 1986 Apr 15;136(8):2883–2891. [PubMed] [Google Scholar]
  24. Montalescot G., Faraggi M., Drobinski G., Messian O., Evans J., Grosgogeat Y., Thomas D. Myocardial viability in patients with Q wave myocardial infarction and no residual ischemia. Circulation. 1992 Jul;86(1):47–55. doi: 10.1161/01.cir.86.1.47. [DOI] [PubMed] [Google Scholar]
  25. Ploplis V. A., Carmeliet P., Vazirzadeh S., Van Vlaenderen I., Moons L., Plow E. F., Collen D. Effects of disruption of the plasminogen gene on thrombosis, growth, and health in mice. Circulation. 1995 Nov 1;92(9):2585–2593. doi: 10.1161/01.cir.92.9.2585. [DOI] [PubMed] [Google Scholar]
  26. Reidy M. A., Irvin C., Lindner V. Migration of arterial wall cells. Expression of plasminogen activators and inhibitors in injured rat arteries. Circ Res. 1996 Mar;78(3):405–414. doi: 10.1161/01.res.78.3.405. [DOI] [PubMed] [Google Scholar]
  27. Reuning U., Bang N. U. Regulation of the urokinase-type plasminogen activator receptor on vascular smooth muscle cells is under the control of thrombin and other mitogens. Arterioscler Thromb. 1992 Oct;12(10):1161–1170. doi: 10.1161/01.atv.12.10.1161. [DOI] [PubMed] [Google Scholar]
  28. Romer J., Bugge T. H., Pyke C., Lund L. R., Flick M. J., Degen J. L., Dano K. Impaired wound healing in mice with a disrupted plasminogen gene. Nat Med. 1996 Mar;2(3):287–292. doi: 10.1038/nm0396-287. [DOI] [PubMed] [Google Scholar]
  29. Saksela O., Rifkin D. B. Cell-associated plasminogen activation: regulation and physiological functions. Annu Rev Cell Biol. 1988;4:93–126. doi: 10.1146/annurev.cb.04.110188.000521. [DOI] [PubMed] [Google Scholar]
  30. Schneiderman J., Bordin G. M., Engelberg I., Adar R., Seiffert D., Thinnes T., Bernstein E. F., Dilley R. B., Loskutoff D. J. Expression of fibrinolytic genes in atherosclerotic abdominal aortic aneurysm wall. A possible mechanism for aneurysm expansion. J Clin Invest. 1995 Jul;96(1):639–645. doi: 10.1172/JCI118079. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Schwartz S. M., Reidy M. A., O'Brien E. R. Assessment of factors important in atherosclerotic occlusion and restenosis. Thromb Haemost. 1995 Jul;74(1):541–551. [PubMed] [Google Scholar]
  32. Tomooka S., Border W. A., Marshall B. C., Noble N. A. Glomerular matrix accumulation is linked to inhibition of the plasmin protease system. Kidney Int. 1992 Dec;42(6):1462–1469. doi: 10.1038/ki.1992.442. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES